Results 181 to 190 of about 16,591 (206)

Integrative transcriptomic profiling reveals subtype-specific therapeutic vulnerabilities and resistance mechanisms in prostate cancer. [PDF]

BMC Cancer
Liu W, Kong W, Jiang S, Wei Y, Yu Z, Cao X, Yang J, Wei X, Shen L, Qin C, Zhu Q.   +10 more
europepmc   +1 more source

Survival benefit associated with first-line androgen receptor pathway inhibitors for de novo metastatic castration-sensitive prostate cancer. [PDF]

Prostate Cancer Prostatic Dis
Freedland SJ, Hong A, El-Chaar N, De Hoedt AM, Kim J, Evans C, Parrish JA, Touya M, Ramaswamy K, Gu L, Polascik TJ.   +10 more
europepmc   +1 more source

Novel Combination of Metronomic Cyclophosphamide and Darolutamide Induces Sustained Clinical Response in Heavily Treated Prostate Cancer with Prostate-Specific Membrane Antigen-Negative Liver Metastases and Rapid Disease Progression. [PDF]

Case Rep Oncol
Patel VM, Cai Q, Ahn R, Hill K, Wang J.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Therapy-Related Myeloid Neoplasms After [¹⁷⁷Lu]Lu-PSMA Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: A Case Series

Journal of Nuclear Medicine
[177Lu]Lu-prostate-specific membrane antigen (PSMA) therapy has a favorable toxicity profile in patients with metastatic castration-resistant prostate cancer (mCRPC). Therapy-related myeloid neoplasm (t-MN) has been described after [177Lu]Lu-DOTATATE but has not, to our knowledge, yet been reported after [177Lu]Lu-PSMA.
Michal, Eifer, Duncan E K, Sutherland, Isaac, Goncalves, James P, Buteau, Lewis, Au, Arun A, Azad, Louise, Emmett, Grace, Kong, Louise, Kostos, Aravind S, Ravi Kumar, Edmond M, Kwan, Elizabeth, Medhurst, Shahneen, Sandhu, Ben, Tran, Alexander W, Wyatt, Michael S, Hofman   +15 more
openaire   +2 more sources

The contemporary management of cancers of the sinonasal tract in adults

Ca-A Cancer Journal for Clinicians, 2023
Rajat Thawani
exaly  

Advances in Understanding and Management of Myeloproliferative Neoplasms

Ca-A Cancer Journal for Clinicians, 2009
Paola Guglielmelli
exaly  

An update on the immune landscape in lung and head and neck cancers

Ca-A Cancer Journal for Clinicians, 2020
Jennifer W Carlisle, Taofeek Kunle Owonikoko, Nabil F Saba   +2 more
exaly  

Recent progress in pancreatic cancer

Ca-A Cancer Journal for Clinicians, 2013
Christopher L Wolfgang, Daniel A Laheru, Elliot Fishman   +2 more
exaly